Moderna
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Trade Moderna 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MRNA
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics.
CEOStéphane Bancel
CEOStéphane Bancel
Employees5,800
Employees5,800
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2010
Founded2010
Employees5,800
Employees5,800
MRNA Key Statistics
Market cap9.97B
Market cap9.97B
Price-Earnings ratio-2.70
Price-Earnings ratio-2.70
Dividend yield—
Dividend yield—
Average volume11.01M
Average volume11.01M
High today$26.52
High today$26.52
Low today$23.15
Low today$23.15
Open price$24.02
Open price$24.02
Volume9.48M
Volume9.48M
52 Week high$170.47
52 Week high$170.47
52 Week low$23.15
52 Week low$23.15
MRNA News
Simply Wall St 1d
Moderna (NasdaqGS:MRNA) Declines 19% Over A Week Amid Market Volatilityexperienced a significant decline of 19% over the past week. This drop can largely be attributed to broader market turbulence, amplified by the steep fall in ma...
Simply Wall St 3d
Moderna, Inc.'s 27% Dip In Price Shows Sentiment Is Matching RevenuesUnfortunately for some shareholders, the Moderna, Inc. ( ) share price has dived 27% in the last thirty days, prolonging recent pain. For any long-term sharehol...
Sherwood News 7d
S&P 500 turns massive losses into solid gainS&P 500 turns massive losses into solid gain It was shaping up just like Thursday and Friday — a tumble in AI darlings leading the market down — until it wasn’...
Analyst ratings
68%
of 28 ratingsBuy
17.9%
Hold
67.9%
Sell
14.3%